Imperva (NASDAQ: IMPV) is one of 185 publicly-traded companies in the “IT Services & Consulting” industry, but how does it contrast to its rivals? We will compare Imperva to related businesses based on the strength of its profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Profitability

This table compares Imperva and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Imperva 3.04% -8.52% -4.99%
Imperva Competitors -20.68% -272.92% -4.86%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Imperva and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Imperva 2 6 8 0 2.38
Imperva Competitors 750 4690 7427 173 2.54

Imperva currently has a consensus target price of $51.33, suggesting a potential upside of 25.05%. As a group, “IT Services & Consulting” companies have a potential downside of 7.05%. Given Imperva’s higher probable upside, analysts clearly believe Imperva is more favorable than its rivals.

Earnings and Valuation

This table compares Imperva and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Imperva $264.45 million -$70.27 million 152.04
Imperva Competitors $2.81 billion $292.92 million 328.40

Imperva’s rivals have higher revenue and earnings than Imperva. Imperva is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

97.0% of Imperva shares are owned by institutional investors. Comparatively, 61.2% of shares of all “IT Services & Consulting” companies are owned by institutional investors. 1.9% of Imperva shares are owned by insiders. Comparatively, 17.1% of shares of all “IT Services & Consulting” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

Imperva has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, Imperva’s rivals have a beta of 1.14, indicating that their average share price is 14% more volatile than the S&P 500.

Summary

Imperva rivals beat Imperva on 7 of the 12 factors compared.

Imperva Company Profile

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.